MercoPress, en Español

Montevideo, November 29th 2021 - 18:30 UTC

Tag: Butantan Institute

  • Thursday, October 7th 2021 - 09:23 UTC

    UK helping Brazil to tackle vaccine innovation and R&D policies

    The Butantan center in Sao Paulo, one of Brazil's leading R&D facilities

    As a result of the Covid-19 pandemic, governments across the world are turning their eyes to the importance of having a strong national life sciences industry – one that is capable of conducting fast, quality research and develop new health technologies to tackle incoming global health security threats.

  • Saturday, March 27th 2021 - 09:03 UTC

    Butantan develops 100% Brazilian covid vaccine

    “ButanVac will be delivered to Brazil in 2021. Great news,” said the Butantan Institute on Twitter.

    The Butantan Institute in Sao Paulo has reportedly developed a vaccine of its own against covid-19 and is awaiting clearance from the National Health Surveillance Agency (Anvisa) to start clinical trials in humans.

  • Wednesday, January 27th 2021 - 20:39 UTC

    Director of Sinovac's intermediary institute said it did not close a deal with Uruguay for vaccine

    The laboratory director contradicted President Lacalle Pou, who announced on Saturday at a press conference the purchase of 1.75 million doses from this laboratory.

    The Director of the Butantan Institute on Tuesday contradicted the words of Uruguayan President Luis Lacalle Pou, assuring that there is not yet a closed agreement between the Uruguayan government and the Chinese laboratory Sinovac for the purchase of the vaccine against Covid-19. However, the institute affirmed that there is a pre-agreement and talks are still ongoing. Lacalle Pou announced on Saturday at a press conference the purchase of 1.75 million doses from this laboratory.